Androgen Deprivation Therapy for Prostate Cancer
Alicia Morgans, MD, MPH, discusses androgen deprivation therapy and its role in treating prostate cancer.
Source: curetoday.com
Stay updated with breaking news from Gnrh Antagonists. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alicia Morgans, MD, MPH, discusses androgen deprivation therapy and its role in treating prostate cancer.
A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.
Although the disease afflicts at least 1 out of every 10 women, endometriosis remains a conundrum for patients and their physicians.
Linzagolix is an oral gonadotropin-releasing hormone antagonist for the management of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.